Advisory Opinions:
OIG NIXES COPAY SUBSIDY
Published on Wed Nov 06, 2013
Drugmakers can’t use Medicare to subsidize patient assistance programs for financially needy beneficiaries, the HHS Office of Inspector General reaffirmed in an advisory opinion released Feb. 12 (No. 03-3). In the opinion, the OIG considers a pharmaceutical manufacturer’s proposal to modify its existing PAP to pay Medicare Part B cost-sharing amounts for needy patients who use its post-organ transplant immunosuppressive products. [...]